US20060276876A1 - Stent, method for processing stent, and method of stenting a patient - Google Patents
Stent, method for processing stent, and method of stenting a patient Download PDFInfo
- Publication number
- US20060276876A1 US20060276876A1 US11/394,556 US39455606A US2006276876A1 US 20060276876 A1 US20060276876 A1 US 20060276876A1 US 39455606 A US39455606 A US 39455606A US 2006276876 A1 US2006276876 A1 US 2006276876A1
- Authority
- US
- United States
- Prior art keywords
- stent
- tia16v4
- nuclear spin
- spin tomography
- stenting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000003325 tomography Methods 0.000 claims abstract description 16
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 11
- 229910052720 vanadium Inorganic materials 0.000 claims abstract description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002253 acid Substances 0.000 claims abstract description 3
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims abstract description 3
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Inorganic materials [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000010333 potassium nitrate Nutrition 0.000 claims abstract description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- 229910052742 iron Inorganic materials 0.000 claims description 10
- 238000005530 etching Methods 0.000 claims description 7
- 230000005389 magnetism Effects 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 208000037803 restenosis Diseases 0.000 claims 8
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 abstract description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract description 3
- 239000010936 titanium Substances 0.000 abstract description 3
- 229910052719 titanium Inorganic materials 0.000 abstract description 3
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 abstract description 3
- 238000003631 wet chemical etching Methods 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 229910001092 metal group alloy Inorganic materials 0.000 abstract 1
- 239000000463 material Substances 0.000 description 8
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S148/00—Metal treatment
- Y10S148/051—Etching
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/901—Method of manufacturing prosthetic device
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/4902—Electromagnet, transformer or inductor
- Y10T29/49021—Magnetic recording reproducing transducer [e.g., tape head, core, etc.]
- Y10T29/49032—Fabricating head structure or component thereof
- Y10T29/49034—Treating to affect magnetic properties
Definitions
- This invention relates to the use of a material in claim 1 and a process in claims 3 and 5 .
- cardiovascular stents that are able to adequately prop open the vessel, that can be accurately positioned and that, and this is new—can be viewed with nuclear spin tomography.
- Traditional stents are made of stainless steel and show distinct image distortions, so called artifacts. These artifacts occur when materials with high magnetic susceptibility are used.
- a goal of the invention is to show means by which the occurrence of artifacts in combination with the stents and nuclear spin tomography can be avoided.
- the above named alloy according to ASTM Grade 9 is harder than an alloy according to ASTM Grade 5 or ISO 3.765 or 3.7165. This would have the following components: 90% titanium, 6% aluminum, and 4% vanadium.
- the material is more flexible than the so-called ASTM grade 9 material and is therefore more suitable for expanding a stent with the help of a balloon catheter.
- Materials that are made to be artifact free but created with tools containing magnetizing components after processing show an increase in screen artifacts which rubbed off the tools.
- a reduction of surface magnetism can be achieved through dipping in etching solutions which etches the materials the tools are made of.
- the rub-off from the tools is eliminated by the wet chemical etching solution.
- Such an etching solution that removes the iron impurities consists for example of 3 parts hydrochloric acid and 2 parts saltpeter acid and can be further reduced with additional parts water in the etching process.
- Stents manufactured in the manner here described can be ideally observed in nuclear spin tomography units in magnetic flux density >1.0 Testa. It was possible, for example with an unexpanded stent having a diameter of 1 mm, that was balloon expanded to a diameter of 4 mm, to clearly see all the stent struts, the so-called strats. It was also possible to get a good look inside the expanded stent. So-called in-stent-restenose in the interior of the stent can be seen when a stent has been treated in this manner.
Abstract
The subject invention pertains instruments for use in nuclear spin tomography comprising a metal alloy comprising aluminum, vanadium, and titanium. In a specific embodiment, the subject invention relates to cardiovascular stents which can exhibit a low incidence of artifacts and are viewable in a nuclear spin tomography unit. The subject invention also pertains to a method for processing instruments for use in nuclear spin tomography. Spin processing can comprise application of a wet chemical etching solution. In a specific embodiment, the wet chemical etching solution can comprise three parts hydrochloric acid and two parts saltpeter acid.
Description
- This application is a divisional application of U.S. patent application Ser. No. 10/851,931, filed May 21, 2004, which is a divisional application of U.S. patent application Ser. No. 10/091,988, filed Mar. 5, 2002, now U.S. Pat. No. 6,780,338, which claims the benefit of German Application Serial No. 20104145.6, filed Mar. 9, 2001, all of which are hereby incorporated by reference herein in their entirety, including any figures, tables, or drawings.
- This invention relates to the use of a material in claim 1 and a process in claims 3 and 5. In today's stent technology it is desirable to use cardiovascular stents that are able to adequately prop open the vessel, that can be accurately positioned and that, and this is new—can be viewed with nuclear spin tomography. Traditional stents are made of stainless steel and show distinct image distortions, so called artifacts. These artifacts occur when materials with high magnetic susceptibility are used.
- A goal of the invention is to show means by which the occurrence of artifacts in combination with the stents and nuclear spin tomography can be avoided.
- The solution is recapitulated in claims 1 through 5.
- An alloy of 3 percent aluminum by weight and 2.5 percent vanadium by weight, with the remainder being titanium, known as material TIA13V2.5 or material No. 3.7194 or 253.7195 (ASTM Grade 9), shows especially few image artifacts and has sufficient hardness to be suitable for interventional instruments used in nuclear spin tomography.
- The above named alloy according to ASTM Grade 9 is harder than an alloy according to ASTM Grade 5 or ISO 3.765 or 3.7165. This would have the following components: 90% titanium, 6% aluminum, and 4% vanadium. The material is more flexible than the so-called ASTM grade 9 material and is therefore more suitable for expanding a stent with the help of a balloon catheter.
- Materials that are made to be artifact free but created with tools containing magnetizing components after processing show an increase in screen artifacts which rubbed off the tools. A reduction of surface magnetism can be achieved through dipping in etching solutions which etches the materials the tools are made of. The rub-off from the tools is eliminated by the wet chemical etching solution. Such an etching solution that removes the iron impurities consists for example of 3 parts hydrochloric acid and 2 parts saltpeter acid and can be further reduced with additional parts water in the etching process.
- Stents manufactured in the manner here described can be ideally observed in nuclear spin tomography units in magnetic flux density >1.0 Testa. It was possible, for example with an unexpanded stent having a diameter of 1 mm, that was balloon expanded to a diameter of 4 mm, to clearly see all the stent struts, the so-called strats. It was also possible to get a good look inside the expanded stent. So-called in-stent-restenose in the interior of the stent can be seen when a stent has been treated in this manner.
Claims (23)
1-5. (canceled)
6. A method for control of in-stent-restenosis, comprising:
positioning a stent in a vessel, wherein the stent comprises TIA13V2.5; and
viewing in-stent-restenosis within an inner lumen of the stent with nuclear spin tomography, wherein the TIA13V2.5 exhibits a low incidence of artifacts in nuclear spin tomography, wherein viewing in-stent-restenosis within the inner lumen of the stent with nuclear spin tomography is useful for control of in-stent-restenosis.
7. The method according to claim 6 ,
wherein the stent consists essentially entirely of TIA13V2.5.
8. The method according to claim 6 , wherein TIA13V2.5 has the following composition by weight:
up to 0.08% C; up to 0.03% N2; up to 0.15% O2; 2.0% to 3.0% V; 2.5% to 3.5% Al; up to 0.25% Fe; up to 0.015% H2; and the balance Ti.
9. The method according to claim 7 ,
wherein TIA13V2.5 has the following composition by weight:
up to 0.08% C; up to 0.03% N2; up to 0.15% O2; 2.0% to 3.0% V; 2.5% to 3.5% Al; up to 0.25% Fe; up to 0.015% H2; and the balance Ti.
10. A method for control of in-stent-restenosis, comprising:
positioning a stent in a vessel, wherein the stent comprises TIA16V4; and
viewing in-stent-restenosis within an inner lumen of the stent with nuclear spin tomography, wherein the TIA16V4 exhibits a low incidence of artifacts in nuclear spin tomography, wherein viewing in-stent-restenosis within the inner lumen of the stent with nuclear spin tomography is useful for control of in-stent-restenosis.
11. The method according to claim 10 ,
wherein the stent is expandable with a balloon catheter.
12. The method according to claim 10 ,
wherein the stent consists essentially entirely of TIA16V4.
13. The method according to claim 10 ,
wherein the TIA16V4 has the following composition by weight:
up to 0.08% C; up to 0.05% N2; up to 0.2% O2; 3.5% to 4.5% V; 5.5% to 6.75% Al; up to 0.4% Fe; up to 0.015% H2; and the balance Ti.
14. The method according to claim 12 ,
wherein the TIA16V4 has the following composition by weight:
up to 0.08% C; up to 0.05% N2; up to 0.2% O2; 3.5% to 4.5% V; 5.5% to 6.75% Al; up to 0.4% Fe; up to 0.015% H2; and the balance Ti.
15. A method of stenting a patient, comprising:
stenting a patient with a stent, wherein the stent comprises:
TIA13V2.5, wherein the TIA13V2.5 exhibits a low incidence of artifacts in nuclear spin tomography.
16. The method according to claim 15 ,
wherein the stent consists essentially entirely of TIA13V2.5.
17. The method according to claim 15 ,
wherein TIA13V2.5 has the following composition by weight:
up to 0.08% C; up to 0.03% N2; up to 0.15% O2; 2.0% to 3.0% V; 2.5% to 3.5% Al; up to 0.25% Fe; less than 0.015% H2; and the balance Ti.
18. The method according to claim 16 ,
wherein TIA13V2.5 has the following composition by weight:
up to 0.08% C; up to 0.03% N2; up to 0.15% O2; 2.0% to 3.0% V; 2.5% to 3.5% Al; up to 0.25% Fe; up to 0.015% H2; and the balance Ti.
19. A method of stenting a patient, comprising:
stenting a patient with a stent, wherein the stent comprises TIA16V4, wherein the TIA16V4 exhibits a low incidence of artifacts in nuclear spin tomography.
20. The method according to claim 19 ,
wherein the stent is expandable with a balloon catheter.
21. The method according to claim 19 ,
wherein the stent consists essentially entirely of TIA16V4.
22. The method according to claim 19 ,
wherein the TIA16V4 has the following composition by weight:
up to 0.08% C; up to 0.05% N2; up to 0.2% O2; 3.5% to 4.5% V; 5.5% to 6.75% Al; up to 0.4% Fe; up to 0.015% H2; and the balance Ti.
23. The method according to claim 21 ,
wherein the TIA16V4 has the following composition by weight:
up to 0.08% C; up to 0.05% N2; up to 0.2% O2; 3.5% to 4.5% V; 5.5% to 6.75% Al; up to 0.4% Fe; up to 0.015% H2; and the balance Ti.
24. A method of stenting a patient, comprising:
stenting a patient with a stent processed with tools containing magnetizing components, wherein prior to stenting the patient exposing the surface of the stent processed with tools containing magnetizing components to an etching solution that etches the magnetizing components, wherein exposing the surface of the stent processed with tools containing magnetizing components reduces surface magnetism of the stent, wherein reducing surface magnetism of the stent reduces the occurrence of artifacts from the stent in nuclear spin tomography.
25. The method according to claim 24 ,
wherein the etching solution etches iron impurities.
26. The method according to claim 25 ,
wherein the etching solution comprises:
3 parts hydrochloric acid; and
2 parts saltpeter acid.
27. The method according to claim 26 ,
wherein the etching solution further comprises water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/394,556 US20060276876A1 (en) | 2001-03-09 | 2006-03-31 | Stent, method for processing stent, and method of stenting a patient |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20104145.6 | 2001-03-09 | ||
| DE20104145U DE20104145U1 (en) | 2001-03-09 | 2001-03-09 | Cardiovascular stent |
| US10/091,988 US6780338B2 (en) | 2001-03-09 | 2002-03-05 | Method for processing a stent processed with tools containing magnetizing components |
| US10/851,931 US20040211491A1 (en) | 2001-03-09 | 2004-05-21 | Stent, method for processing stent, and method of stenting a patient |
| US11/394,556 US20060276876A1 (en) | 2001-03-09 | 2006-03-31 | Stent, method for processing stent, and method of stenting a patient |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/851,931 Division US20040211491A1 (en) | 2001-03-09 | 2004-05-21 | Stent, method for processing stent, and method of stenting a patient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20060276876A1 true US20060276876A1 (en) | 2006-12-07 |
Family
ID=7954090
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/091,988 Expired - Lifetime US6780338B2 (en) | 2001-03-09 | 2002-03-05 | Method for processing a stent processed with tools containing magnetizing components |
| US10/851,931 Abandoned US20040211491A1 (en) | 2001-03-09 | 2004-05-21 | Stent, method for processing stent, and method of stenting a patient |
| US11/394,556 Abandoned US20060276876A1 (en) | 2001-03-09 | 2006-03-31 | Stent, method for processing stent, and method of stenting a patient |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/091,988 Expired - Lifetime US6780338B2 (en) | 2001-03-09 | 2002-03-05 | Method for processing a stent processed with tools containing magnetizing components |
| US10/851,931 Abandoned US20040211491A1 (en) | 2001-03-09 | 2004-05-21 | Stent, method for processing stent, and method of stenting a patient |
Country Status (2)
| Country | Link |
|---|---|
| US (3) | US6780338B2 (en) |
| DE (1) | DE20104145U1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006036786A2 (en) * | 2004-09-27 | 2006-04-06 | Cook Incorporated | Mri compatible metal devices |
| US20080249607A1 (en) * | 2005-09-20 | 2008-10-09 | Thomas Jay Webster | Biocompatable Nanophase Materials |
| JP2008036076A (en) * | 2006-08-04 | 2008-02-21 | Japan Health Science Foundation | Balloon-expandable stent and its production method |
| US8380311B2 (en) * | 2006-10-31 | 2013-02-19 | Medtronic, Inc. | Housing for implantable medical device |
| US20080103543A1 (en) * | 2006-10-31 | 2008-05-01 | Medtronic, Inc. | Implantable medical device with titanium alloy housing |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5733326A (en) * | 1996-05-28 | 1998-03-31 | Cordis Corporation | Composite material endoprosthesis |
| US6010445A (en) * | 1997-09-11 | 2000-01-04 | Implant Sciences Corporation | Radioactive medical device and process |
| US6183508B1 (en) * | 1996-02-08 | 2001-02-06 | Schneider Inc | Method for treating a vessel with a titanium alloy stent |
| US6183409B1 (en) * | 1998-02-10 | 2001-02-06 | Implant Sciences Corporation | Soft x-ray emitting radioactive stent |
| US6258182B1 (en) * | 1998-03-05 | 2001-07-10 | Memry Corporation | Pseudoelastic β titanium alloy and uses therefor |
| US6325824B2 (en) * | 1998-07-22 | 2001-12-04 | Advanced Cardiovascular Systems, Inc. | Crush resistant stent |
| US6527938B2 (en) * | 2001-06-21 | 2003-03-04 | Syntheon, Llc | Method for microporous surface modification of implantable metallic medical articles |
| US6551341B2 (en) * | 2001-06-14 | 2003-04-22 | Advanced Cardiovascular Systems, Inc. | Devices configured from strain hardened Ni Ti tubing |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19531117C2 (en) * | 1995-08-24 | 1999-05-12 | Daum Gmbh | Use of a titanium alloy for instruments for interventional magnetic resonance imaging and methods for the treatment of such instruments |
-
2001
- 2001-03-09 DE DE20104145U patent/DE20104145U1/en not_active Expired - Lifetime
-
2002
- 2002-03-05 US US10/091,988 patent/US6780338B2/en not_active Expired - Lifetime
-
2004
- 2004-05-21 US US10/851,931 patent/US20040211491A1/en not_active Abandoned
-
2006
- 2006-03-31 US US11/394,556 patent/US20060276876A1/en not_active Abandoned
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6183508B1 (en) * | 1996-02-08 | 2001-02-06 | Schneider Inc | Method for treating a vessel with a titanium alloy stent |
| US5733326A (en) * | 1996-05-28 | 1998-03-31 | Cordis Corporation | Composite material endoprosthesis |
| US6010445A (en) * | 1997-09-11 | 2000-01-04 | Implant Sciences Corporation | Radioactive medical device and process |
| US6183409B1 (en) * | 1998-02-10 | 2001-02-06 | Implant Sciences Corporation | Soft x-ray emitting radioactive stent |
| US6258182B1 (en) * | 1998-03-05 | 2001-07-10 | Memry Corporation | Pseudoelastic β titanium alloy and uses therefor |
| US6325824B2 (en) * | 1998-07-22 | 2001-12-04 | Advanced Cardiovascular Systems, Inc. | Crush resistant stent |
| US6551341B2 (en) * | 2001-06-14 | 2003-04-22 | Advanced Cardiovascular Systems, Inc. | Devices configured from strain hardened Ni Ti tubing |
| US6527938B2 (en) * | 2001-06-21 | 2003-03-04 | Syntheon, Llc | Method for microporous surface modification of implantable metallic medical articles |
Also Published As
| Publication number | Publication date |
|---|---|
| US20040211491A1 (en) | 2004-10-28 |
| DE20104145U1 (en) | 2002-10-31 |
| US20030078675A1 (en) | 2003-04-24 |
| US6780338B2 (en) | 2004-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7128757B2 (en) | Radiopaque and MRI compatible nitinol alloys for medical devices | |
| US20060276876A1 (en) | Stent, method for processing stent, and method of stenting a patient | |
| EP1581277B1 (en) | Medical devices | |
| EP1355685B1 (en) | Radiopaque nitinol alloys for medical devices | |
| Poncin et al. | Stent tubing: understanding the desired attributes | |
| US7727273B2 (en) | Medical devices and methods of making the same | |
| DE60003490T2 (en) | A Ti-Zr alloy and medical devices made from it | |
| US6569194B1 (en) | Thermoelastic and superelastic Ni-Ti-W alloy | |
| DE60309281T3 (en) | Improved metal alloy for medical devices and implants | |
| JP6388883B2 (en) | Medical devices visible in MRI | |
| EP2640432B1 (en) | Radiopaque intraluminal stents comprising cobalt-based alloys containing one or more platinum group metals, refractory metals, or combinations thereof | |
| EP1604691A2 (en) | Biocompatible alloy for implantable medical devices | |
| US20090099645A1 (en) | Radiopaque markers and medical devices comprising binary alloys of titanium | |
| EP1545679B1 (en) | Radiopaque nitinol alloys for medical devices | |
| Li et al. | MRI compatible Nb–Ta–Zr alloys used for vascular stents: Optimization for mechanical properties | |
| US20140257451A1 (en) | Medical device utilizing a nickel-titanium ternary alloy having high elastic modulus | |
| Li et al. | Role of fine nano-scaled isothermal omega phase on the mechanical and superelastic properties of a high Zr-containing Ti–Zr–Nb–Sn shape memory alloy | |
| EP1604692B1 (en) | Cobalt-nickel-chromium biocompatible alloy for implantable medical devices | |
| US20180078742A1 (en) | Radiopaque Composite Wire for Medical Applications and Method of Making a Radiopaque Composite Wire | |
| Li et al. | Tuning the texture characteristics and superelastic behaviors of Ti–Zr–Nb–Sn shape memory alloys by varying Nb content | |
| JP2006175211A (en) | Cobalt-chromium-molybdenum alloy durable against fatigue for intravascular medical device | |
| CA2511149C (en) | Improved magnetic resonance imaging compatibility alloy for implantable medical devices | |
| O’Brien et al. | Initial exploration of Ti–Ta, Ti–Ta–Ir and Ti–Ir alloys: candidate materials for coronary stents | |
| Craig et al. | Development of a platinum-enhanced radiopaque stainless steel (PERSS®) | |
| JP2005281728A (en) | SHAPE MEMORY ELEMENT MADE OF Ti-BASED ALLOY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: MRI DEVICES DAUM GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DAUM, WOLFGANG;REEL/FRAME:017514/0757 Effective date: 20020317 Owner name: INVIVO GERMANY GMBH, GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:MRI DEVICES DAUM GMBH;REEL/FRAME:017514/0798 Effective date: 20050713 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |